Report #2840781

Overview

Sex

Female

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

patient developed nausea; vomiting; This non-serious case was reported by a consumer via sales rep and described the occurrence of nausea in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, several hours after receiving Shingrix, the patient experienced nausea (Verbatim: patient developed nausea) and vomiting (Verbatim: vomiting). Shingrix was discontinued. The outcome of the nausea and vomiting were not reported. It was unknown if the reporter considered the nausea and vomiting to be related to Shingrix. It was unknown if the company considered the nausea and vomiting to be related to Shingrix. Additional Information: GSK Receipt Date: 09-MAY-2025 The reporter reported that the patient took the 1 dose of the Shingrix. Within a few hours the patient developed nausea and vomiting. Her side effects were so severe that her doctor decided not to give her dose 2 of the series.